Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
Completed · Not applicable
Conditions studied: Anxiety Disorders, Depressive Disorder
In brief
This two phase study is testing an online version of a transdiagnostic, cognitive behavioral therapy, against a modified version of that therapy emphasizing positive affect. The first phase of the trial will focus on content development for the modified therapy and the second phase will be a randomized control trial comparing the two.
Key facts
- Study ID
- NCT05120232
- Run by
- Boston University Charles River Campus
- People needed
- 125
- Starts
- 2021-03-08
- Expected to finish
- 2024-01-16
- Last updated by the study team
- 2025-02-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with a DSM-5 anxiety, obsessive-compulsive, or depressive disorder
You may not qualify if…
- Acute risk factors (suicidal or homicidal ideation or clinical condition requiring immediate treatment);
- The individual is in treatment elsewhere for related issues; and/or
- The individual is considering changing their treatment and and/or psychotropic medication during the time period in which they would be enrolled in the study and/or
- The individual is unable or unwilling to commit to the study procedures.
Where it is running
- Center for Anxiety and Related Disorders - Boston University — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.